-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $500

Benzinga·10/30/2026 20:33:04
TD Cowen analyst Brendan Smith maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $420 to $500.